P55417A
©2018 Pearson Education Ltd.
1/1/1/1/1/
Turn over    
Instructions
•	Use black ink or ball-point pen.
•	Fill in the boxes at the top of this page with your name,  
centre number and candidate number.
•	Answer all questions.
•	Answer the questions in the spaces provided  
– there may be more space than you need.
Information
•	The total mark for this paper is 80.
•	The marks for each question are shown in brackets  
– use this as a guide as to how much time to spend on each question. 
•	Questions labeled with an asterisk (*) are ones where the quality of your 
spelling, punctuation and grammar, as well as the clarity of expression may 
be assessed.
•	Candidates may use a calculator. 
Advice
•	Read each question carefully before you start to answer it.
•	Keep an eye on the time.
•	Try to answer every question.
•	Check your answers if you have time at the end.
Pearson Edexcel 
International
Advanced Level
Centre Number
Candidate Number
Total Marks
You must have: 
Calculator, HB pencil, ruler
Biology
Advanced Subsidiary
Unit 1: Lifestyle, Transport, Genes and Health
Morning (Time: 1 hour 30 minutes)
Paper Reference WBI01/01
Monday 8 October 2018
Candidate surname
Please check the examination details below before entering your candidate information
Other names
*P55417A0124*


--- Page Break ---

2
*P55417A0224*
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
Answer ALL questions.  Write your answers in the spaces provided.
Some questions must be answered with a cross in a box 
.  If you change your mind about an 
answer, put a line through the box 
 and then mark your new answer with a cross 
.
1	 There is a variety of organic molecules in living organisms.
	
(a)	 Put a cross (
) in the box to complete each of the following statements.
	
	
(i)	 Monosaccharides form disaccharides by the formation of 
(1)
	
	
	
A	 a glycosidic bond
	
	
	
B	 a hydrogen bond
	
	
	
C	 an ester bond
	
	
	
D	 an ionic bond
	
	
(ii)	 Glycogen can be converted to glucose. 
	
	
	
The type of reaction taking place is
(1)
	
	
	
A	 condensation
	
	
	
B	 esterification
	
	
	
C	 hydrolysis
	
	
	
D	 replication
	
(b)	 The diagram below shows the structure of the amino acid glycine.
C
H
COOH
H
H2N


--- Page Break ---

3
*P55417A0324*
Turn over    
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
	
	
(i)	 Draw a diagram to show the structure of the molecules produced when 
two molecules of glycine are joined together.
(3)
	
	
(ii)	 Name the type of molecule produced when several amino acids are 
joined together.
(1)
.....................................................................................................................................................................................................................................................................................
	
(c)	 Explain how water is involved in the transport of molecules in living organisms.
(3)
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
(Total for Question 1 = 9 marks)


--- Page Break ---

4
*P55417A0424*
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
2	 The development of cardiovascular disease (CVD) is often linked to high blood pressure.
	
(a)	 Explain what is meant by the term cardiovascular disease.
(2)
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
	
(b)	 Put a cross (
) in the box to complete the following statement.
	
	
Drugs used to treat high blood pressure are called
(1)
	
	
A	 anticoagulants
	
	
B	 antihypertensives
	
	
C	 platelet inhibitors
	
	
D	 statins
	
(c)	 State two risk factors, other than high blood pressure, that contribute to the 
development of CVD.
(2)
1..................................................................................................................................................................................................................................................................................
2..................................................................................................................................................................................................................................................................................


--- Page Break ---

5
*P55417A0524*
Turn over    
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
	
(d)	 The table below shows the death rate from CVD in various European countries in 
2011.  Males and females under the age of 65 are included in the data. 
Countries
Death rate from CVD  
/ per 100 000 of population
France, Italy, Israel
under 40
Ireland, Germany
40 to 49
Finland, Malta
50 to 59
Turkey, Poland
60 and over
	
	
(i)	 Suggest why the data are presented as deaths per 100 000.
(1)
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
	
	
(ii)	 In Poland, the death rate from CVD in 2011 was 115 per 100 000 of population. 
In 2001, the death rate from CVD was 141 per 100 000. 
	
	
	
Calculate the percentage decrease in the death rate.
	
	
	
Show your working.
(2)
............................................................... %


--- Page Break ---

6
*P55417A0624*
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
	
	
(iii)	Suggest an explanation for the difference in the death rates from CVD in 
Poland between 2001 and 2011.
(3)
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
(Total for Question 2 = 11 marks)


--- Page Break ---

7
*P55417A0724*
Turn over    
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
3	 The photograph below shows a hand of a person with Marfan syndrome on the left.
	
The photograph also shows a hand of an unaffected person on the right.
	
Marfan syndrome affects 1 in 4 000 people.  This syndrome is caused by a gene 
mutation that is a dominant allele.
	
(a)	 Explain what is meant by each of the following terms.
	
	
(i)	 Gene mutation
(2)
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
	
	
(ii)	 Dominant allele
(2)
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................


--- Page Break ---

8
*P55417A0824*
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
	
(b)	 (i)	 Draw a genetic diagram to show all the possible children of a male 
heterozygous for this syndrome and an unaffected female. 
	
	
	
On your diagram, show the genotypes and the phenotypes of the parents and 
their children.
(4)
	
	
(ii)	 The first child of these parents is affected by this syndrome.
	
	
	
State the probability that their next child will also have this syndrome.
(1)
.....................................................................................................................................................................................................................................................................................
(Total for Question 3 = 9 marks)


--- Page Break ---

9
*P55417A0924*
Turn over    
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
4	 Polynucleotides, DNA and RNA, are involved in protein synthesis.
	
(a)	 Put a cross (
) in the box to complete the following statement.
	
	
Both DNA and RNA
(1)
	
	
A	 are single-stranded
	
	
B	 contain deoxyribose 
	
	
C	 contain phosphate groups
	
	
D	 contain uracil
	
(b)	 (i)	 The diagram below shows the messenger RNA base sequence produced from 
a DNA strand.
U
G
A
A
G
C
G
G
C
U
	
	
	
Write the sequence of bases in the original DNA template strand in the boxes below.
(2)
	
	
(ii)	 Put a cross (
) in the box to complete the following statement.
	
	
	
The number of codons in a messenger RNA molecule containing 
900 mononucleotides is
(1)
	
	
	
A	 100
	
	
	
B	 300
	
	
	
C	 600
	
	
	
D	 900


--- Page Break ---

10
*P55417A01024*
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
	
 *(c)	 Describe the stage of protein synthesis that occurs in the nucleus of a cell.
(5)
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
(Total for Question 4 = 9 marks)


--- Page Break ---

11
*P55417A01124*
Turn over    
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
5	 About 22% of the current UK population are classified as being obese.  Obesity is 
linked to the development of CVD and type 2 diabetes.
	
Obesity can be estimated using the body mass index (BMI).  BMI is calculated using 
the formula below.
BMI = mass in kilograms
height in metres
(
)2
	
(a)	 Calculate the mass of a person with a BMI of 30 and a height of 1.95 metres.
(2)
............................................................... kg


--- Page Break ---

12
*P55417A01224*
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
	
(b)	 Type 2 diabetes can be caused by the pancreas not producing enough of the 
hormone insulin.  As a result, blood glucose levels remain high.
	
	
Studies show that about 90% of people with type 2 diabetes in the UK have a BMI 
over 30.
	
	
The graph below shows the results of a recent study to investigate the link 
between type 2 diabetes and BMI in both men and women.
100
80
60
40
20
0
< 20
20–24
25–29
30–34
35–39
 40
BMI
Percentage with type 2 diabetes (%)
Key
 men
 women
	
	
(i)	 Using the information in the graph, describe the relationship between BMI 
and the incidence of type 2 diabetes in men.
(2)
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................


--- Page Break ---

13
*P55417A01324*
Turn over    
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
	
	
(ii)	 Compare the incidence of type 2 diabetes in men and in women.
(3)
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
	
(c)	 Suggest how an obese man should change his lifestyle.
(2)
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
	
(d)	 Food diaries are a way of allowing people with type 2 diabetes to monitor their 
diet at home by recording their daily diet. 
	
	
Suggest two reasons why this might not be a reliable method for monitoring diet.
(2)
1..................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
2..................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
(Total for Question 5 = 11 marks)


--- Page Break ---

14
*P55417A01424*
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
6	 Blood clots in veins and arteries may lead to heart attacks. 
	
(a)	 (i)	 Put a cross (
) in the box that completes the following statement.
(1)
	
	
	
The role of thrombin in the blood clotting process is to
	
	
	
A	 activate the enzyme thromboplastin
	
	
	
B	 catalyse the conversion of fibrinogen to fibrin
	
	
	
C	 stimulate the release of fibrinogen 
	
	
	
D	 stimulate the release of prothrombin
	
	
(ii)	 Explain how a blood clot can cause a heart attack.
(3)
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................


--- Page Break ---

15
*P55417A01524*
Turn over    
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
	
(b)	 The photograph below shows a cross section of a large vein, as seen using a 
light microscope. 
X
Y
Magnification ×12
	
	
Calculate the actual thickness of the wall of this vein between X and Y.
	
	
Show your working.
(2)
................................ mm 


--- Page Break ---

16
*P55417A01624*
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
	
 *(c)	 Explain how the structure of an artery is related to its function.
(5)
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
(Total for Question 6 = 11 marks)


--- Page Break ---

17
*P55417A01724*
Turn over    
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
7	 Cystic fibrosis is an inherited disorder caused by a mutation in the CFTR gene.
	
(a)	 Explain how a mutation in the CFTR gene affects movement of water through the 
cell membrane.
(3)
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
	
(b)	 Cystic fibrosis affects 1 in 3 000 children born in the UK.  This disorder can be 
detected by prenatal genetic testing.
	
	
(i)	 Name one type of prenatal testing.  Describe how this is carried out.
(3)
Type........................................................................................................................................................................................................................................................................
How this is carried out.........................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................


--- Page Break ---

18
*P55417A01824*
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
	
	
(ii)	 Suggest why prenatal testing for cystic fibrosis is not offered to all pregnant women.    
(1)
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
	
	
(iii)	Discuss the ethical issues relating to the use of genetic screening.  
(3)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
(Total for Question 7 = 10 marks)


--- Page Break ---

19
*P55417A01924*
Turn over    
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
BLANK PAGE


--- Page Break ---

20
*P55417A02024*
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
8	 The photograph below shows two germinating pea seeds.
Magnification ×1
	
Germinating peas contain an enzyme that breaks down starch.
	
The effect of temperature on the activity of this enzyme was investigated. 
	
The rate of decrease in the mass of starch in germinating peas was measured at six 
temperatures.
	
The graph below shows the results of this investigation.
35
30
25
20
15
10
5
0
0
10
20
30
40
50
60
Temperature / °C
Rate of decrease in mass / mg min−1


--- Page Break ---

21
*P55417A02124*
Turn over    
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
	
(a)	 Using the information in the graph, describe the relationship between the activity 
of this enzyme and temperature.
(3)
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
	
(b)	 Explain why increasing the temperature above 40 °C causes a change in the rate 
of decrease in the mass of starch.
(3)
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................


--- Page Break ---

22
*P55417A02224*
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
	
(c)	 Describe an experiment that could be carried out to confirm the results of 
this investigation.
(4)
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
.....................................................................................................................................................................................................................................................................................
(Total for Question 8 = 10 marks)
TOTAL FOR PAPER = 80 MARKS


--- Page Break ---

23
*P55417A02324*
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
BLANK PAGE


--- Page Break ---

24
*P55417A02424*
	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA	
DO NOT WRITE IN THIS AREA
BLANK PAGE
Every effort has been made to contact copyright holders to obtain their permission for the use of copyright material. 
Pearson Education Ltd. will, if notified, be happy to rectify any errors or omissions and include any such rectifications in 
future editions.
